BCL Inhibitors Proteasome Inhibitors CD Protein Inhibitors Immune Checkpoint Inhibitors Immunotherapy Threonine-Tyrosine Kinase Inhibitors Serine-Threonine Kinase Inhibitors PI3 Kinase Inhibitors Interleukins Other Epigenetics | Multiple Myeloma | Mantle Cell Lymphoma | Leukemia |
---|---|---|---|
BRAF inhibitor | |||
VenVd | |||
VTD | |||
venetoclax | |||
BRAF inhibitor + MEK inhibitor | |||
VRD | |||
TD | |||
DOT1L inhibitor + venetoclax | |||
venetoclax + bortezomib | |||
venetoclax + cobimetinib | |||
venetoclax + atezolizumab + cobimetinib | |||
bortezomib | |||
venetoclax + daratumumab | |||
INCB50465 | |||
pomalidomide | |||
ARRY-520 | |||
venetoclax + selinexor | |||
BGB-11417 | |||
lenalidomide | |||
APG-2575 |